ArticleThe oncologist2026

Clinical outcomes of lutetium-177-PSMA-617 in a racially diverse cohort of patients with metastatic castration-resistant prostate cancer.

Margo Brooke Gerke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.